IL-2 Plus Abatacept in FTD

Clinical trial NCT06395038 · UNKNOWN

Trial details

NCT number: NCT06395038
Sponsor: The Methodist Hospital Research Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Frontotemporal Degeneration

Start date: 2024-05-06
Primary completion: 2026-04-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.